IVF INVO Fertility, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$0,86
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,4552 haftanın en düşüğü
$4,9052 haftanın en yükseği
Piyasa Değeri (MRQ)
$2M
P/E (TTM)
-0.0
Hisse Başına Kâr (TTM)
$-230.47
Gelir (TTM)
$8M
rozetleriniz
52 Haftlık Aralık
$0–$5
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$20
P/E
-0.0
ROE
-63.1%
Net Kâr Marjı
-80.2%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
IVF Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.85
Piyasa Değeri (MRQ)
$2M
P/E (TTM)
-0.0
Hisse Başına Kâr (TTM)
$-230.47
Gelir (TTM)
$8M
ROE (TTM)
-63.1%
D/E Borç/Özsermaye (MRQ)
0.1
52 Haftlık Aralık
$0–$5
IVF Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 27 Mart 2026 | 1-for-5 | Ters |
| 28 Kasım 2025 | 1-for-8 | Ters |
| 21 Temmuz 2025 | 1-for-3 | Ters |
| 18 Mart 2025 | 1-for-12 | Ters |
| 28 Temmuz 2023 | 1-for-20 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$7M2022-12-31 → 2025-12-31
Hisse Başına Kâr$-214.642022-12-31 → 2025-12-31
Serbest Nakit Akışı·2023-12-31 → 2023-12-31
Net kar marjı-80.2%2023-12-31 → 2023-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | IVF | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -0.05Y ort. ≈-0.6 | ≈-0.6 | · | · | |
| F/S (TTM) | 0.3 | · | 1.6 | Düşük değerli | |
| F/D (MRQ) | 0.1 | · | 0.7 | Düşük değerli | |
| Fiyat / Maddi Defter Değeri (MRQ) | 0.1 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | IVF | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 132.5% | · | -336.6% | En üst düzey | |
| FAVÖK Marjı (TTM) | 140.0% | · | -336.6% | En üst düzey | |
| Net Kâr Marjı (TTM) | -80.2% | · | -143.8% | En üst düzey | |
| ROA (TTM) | -26.7% | · | -99.4% | En üst düzey | |
| ROE (TTM) | -63.1% | · | -238.1% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | IVF | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.1 | · | 0.1 | Aynı seviyede | |
| Cari Oran (MRQ) | 0.7 | · | 1.4 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.0 | · | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | IVF | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 4.7%5Y ort. ≈129.5% | ≈129.5% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 102.6%5Y ort. ≈53.9% | ≈53.9% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 45.8% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | IVF | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$171.0K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-1915.2%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 14, 2026 | $-0.60 | $-0.71 | 15.1% |
| 31 Mart 2026 | May 20, 2026 | $-3.38 | $-1.26 | -167.7% |
| 31 Aralık 2025 | Haz 2, 2026 | $-196.81 | $-2.78 | -6985.9% |
| 30 Eylül 2025 | $-0.77 | $-0.04 | -1805.9% | |
| 31 Aralık 2024 | $-3104.40 | $-424.20 | -631.8% | |
| 30 Eylül 2023 | $-0.70 | — | — | |
| 30 Haziran 2023 | $-3.06 | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $7M | $3M | $822.2K | $4M | $1M | $1M | $494.4K | $282.1K | $50.9K | $11.7K | $16.6K | |
| Cost of Revenue | $30.6K | $12.2K | $2M | $286.9K | $126.3K | $79.0K | $133.7K | $90.4K | $52.0K | $15.1K | $7.8K | · | |
| Gross Profit | · | · | · | $490.7K | $4M | $948.5K | $1M | $404.0K | $230.2K | $35.8K | $3.9K | $8.9K | |
| R&D Expense | · | $4.9K | $165.9K | $544.0K | $216.4K | $398.4K | $0 | · | · | · | · | · | |
| SG&A Expense | $8M | $8M | $7M | $10M | $9M | $6M | $3M | $3M | $870.6K | $2M | $599.0K | $2M | |
| Operating Expenses | $14M | $13M | $10M | $11M | $9M | $6M | $3M | $3M | $870.6K | $2M | $599.0K | $2M | |
| Operating Income | $-7M | $-7M | $-7M | $-11M | $-5M | $-6M | $-2M | $-3M | $-640.4K | $-2M | $-595.1K | $-2M | |
| Interest Expense | · | $1M | $925.9K | $59.4K | $1M | $3M | $387.6K | $442.0K | $20.9K | $13.8K | $32.0K | $51.9K | |
| Interest Income | · | · | · | · | · | $4.2K | $8.6K | · | · | · | · | · | |
| Other Non-op | $2M | $-972.0K | $-1M | $-263.2K | $-1M | $-3M | $-379.0K | $-442.0K | $-61.7K | · | · | · | |
| Pretax Income | $-5M | $-8M | $-8M | $-11M | $-7M | $-8M | $-2M | $-3M | $-702.2K | $-2M | $-5M | $-2M | |
| Income Tax | $-150.4K | $140.2K | $27.8K | $2.9K | $4.8K | $36 | $433 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-23M | $-9M | $-8M | $-11M | $-7M | $-8M | $-2M | $-3M | $-702.2K | $-2M | $-5M | $-2M | |
| EPS (Basic) | $-214.64 | $-3782.65 | $-67.37 | $-17.97 | $-0.63 | $-1.52 | $-0.45 | $-0.02 | $0.00 | $-0.02 | $-0.04 | $-0.02 | |
| EPS (Diluted) | $-214.64 | $-3782.65 | $-67.37 | $-17.97 | $-0.63 | $-1.52 | $-0.45 | $-0.02 | $0.00 | $-0.02 | $-0.04 | $-0.02 | |
| Shares (Basic) | 117,083 | 2,514 | 119,264 | 606,130 | 10,632,413 | 5,489,738 | 4,854,878 | 147,333,051 | 141,305,050 | 139,186,557 | 128,567,615 | 112,672,160 | |
| Shares (Diluted) | 117,083 | 2,514 | 119,264 | 606,130 | 10,632,413 | 5,489,738 | 4,854,878 | 147,333,051 | 141,305,050 | 139,186,557 | 128,567,615 | 112,672,160 | |
| EBITDA | · | · | $-7M | · | · | · | $-2M | · | $-637.6K | $-2M | $-589.4K | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $619.5K | $232.4K | $90.1K | $6M | $10M | $1M | $212.2K | $25.8K | $152.4K | $492.0K | $18.6K | |
| Receivables | $217.3K | $113.1K | $140.6K | $77.1K | $50.5K | $21.7K | $7.6K | $225.9K | $86.7K | $2.8K | $1.3K | $321 | |
| Inventory | $225.3K | $219.8K | $264.5K | $263.6K | $287.8K | $265.4K | $101.4K | $43.5K | $58.9K | $85.2K | $65.4K | $62.5K | |
| Prepaid Expense | $241.1K | $180.9K | $622.3K | $190.2K | $282.8K | $157.7K | $195.9K | $249.5K | $63.0K | $11.0K | $0 | $0 | |
| Current Assets | $3M | $1M | $1M | $621.1K | $6M | $11M | $2M | $731.1K | $234.4K | $251.4K | $558.8K | $81.4K | |
| PP&E (Net) | $386.2K | $466.7K | $826.4K | $436.7K | $501.4K | $132.2K | $93.1K | $34.4K | $15.7K | $15.7K | $0 | $0 | |
| Accum. Depreciation | $459.6K | $335.7K | $233.6K | $153.3K | $78.2K | $52.3K | $42.1K | $35.9K | · | · | · | · | |
| Goodwill | $6M | $6M | $6M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $1M | $3M | $4M | · | $132.1K | $95.0K | $7.2K | $11.8K | $16.3K | $19.1K | $21.0K | $26.6K | |
| Other Non-current Assets | · | · | · | · | · | $272.6K | $159.0K | $11.8K | $16.3K | $19.1K | $21.0K | $26.6K | |
| Total Assets | $20M | $46M | $19M | $4M | $10M | $11M | $2M | $777.3K | $266.4K | $286.2K | $579.8K | $108.1K | |
| Accounts Payable | $2M | $3M | $2M | $1M | $443.4K | $328.9K | $371.5K | $571.8K | $960.7K | $974.9K | $1M | $1M | |
| Short-term Debt | · | · | · | $100.0K | · | $157.6K | $0 | $131.7K | $0 | · | · | · | |
| Current Liabilities | $10M | $18M | $8M | $3M | $1M | $2M | $2M | $4M | $5M | $5M | $4M | $4M | |
| Capital Leases | $1M | $1M | $3M | $1M | $2M | $58.6K | $81.5K | $0 | · | · | · | · | |
| Deferred Tax | · | $163.1K | · | $1.9K | $1.1K | $469 | $433 | $0 | · | · | · | · | |
| Total Liabilities | $13M | $26M | $18M | $5M | $3M | $5M | $6M | $4M | $5M | $5M | $4M | $4M | |
| Long-term Debt | $892.5K | $7M | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Common Stock | $239 | $37 | $20 | $61 | $1.2K | $964 | $489 | $15.4K | $14.2K | $14.1K | $13.7K | $12.0K | |
| Paid-in Capital | · | · | · | · | $46M | $38M | $20M | $19M | $14M | $13M | $12M | $6M | |
| Retained Earnings | $-91M | $-67M | $-58M | $-50M | $-39M | $-32M | $-24M | $-22M | $-19M | $-18M | $-16M | $-11M | |
| Stockholders' Equity | $7M | $13M | $892.8K | $-977.6K | $7M | $6M | $-4M | $-3M | $-5M | $-5M | $-4M | $-4M | |
| Liabilities + Equity | $20M | $46M | $19M | $4M | $10M | $11M | $2M | $777.3K | $266.4K | $286.2K | $579.8K | $108.1K | |
| Shares Outstanding | 477,366 | 3,111 | 207,711 | 608,611 | 11,929,147 | 9,639,268 | 4,884,879 | 4,821,641 | 142,132,374 | 140,596,646 | 137,085,646 | 119,732,270 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $677.4K | $919.6K | $200.9K | $77.3K | $27.8K | $11.9K | $10.8K | $5.2K | $2.8K | $1.9K | $5.6K | $10.5K | |
| Stock-based Comp | $162.9K | · | · | $2M | $2M | $1M | $69.8K | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Amort. of Intangibles | $553.4K | $817.5K | $120.6K | $1.8K | $1.8K | $1.8K | $4.6K | · | · | · | · | · | |
| Other Non-cash | · | · | $3M | · | · | · | $3M | · | $518.1K | $2M | $5M | · | |
| Operating Cash Flow | $-7M | $-3M | $-5M | $-7M | $-6M | $-5M | $1M | $-653.0K | $-181.3K | $-323.9K | $-151.6K | $-19.4K | |
| CapEx | $43.4K | $183.7K | $444.7K | $10.8K | $415.7K | $49.3K | $64.8K | $19.4K | $0 | $15.7K | $0 | · | |
| Investing Cash Flow | $-3M | $363.9K | $-2M | $-81.2K | $-2M | $-187.3K | $-114.7K | $-19.4K | $0 | $-15.7K | $0 | · | |
| Stock Issued | $12M | $165.1K | $6M | $289.8K | $4M | $11M | $0 | $47.0K | $54.6K | $0 | $645.0K | $20.0K | |
| Net Stock Activity | · | · | $6M | · | · | · | $0 | · | $54.6K | $0 | $645.0K | · | |
| Financing Cash Flow | $11M | $3M | $7M | $1M | $4M | $14M | $-229.5K | $858.9K | $54.6K | $0 | $625.0K | $20.0K | |
| Net Change in Cash | $1M | $509.0K | $142.3K | $-6M | $-4M | $9M | · | $186.5K | $-126.6K | $-339.6K | $473.4K | $599 | |
| Taxes Paid | · | · | · | $800 | $3.3K | $1.1K | · | · | · | · | · | · | |
| Free Cash Flow | · | · | $-5M | · | · | · | $1M | · | $-181.3K | $-339.6K | · | · | |
| Levered FCF | · | · | $-6M | · | · | · | $926.6K | · | $-202.1K | $-353.4K | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 90.6% | · | 81.6% | 70.3% | 33.2% | · | |
| Operating Margin | · | · | -224.0% | · | · | · | -120.8% | · | -227.0% | -4146.1% | -5090.9% | · | |
| Net Margin | · | · | -266.0% | · | · | · | -146.4% | · | -248.9% | -4173.3% | -42426.6% | · | |
| Pretax Margin | · | · | -265.1% | · | · | · | -146.4% | · | -248.9% | -4173.3% | -42426.6% | · | |
| EBITDA Margin | · | · | -217.4% | · | · | · | -120.1% | · | -226.0% | -4142.4% | -5042.7% | · | |
| ROA | · | · | · | · | · | · | -168.5% | · | -254.1% | -490.6% | -1273.3% | · | |
| ROE | · | · | · | · | · | · | 58.0% | · | 14.6% | 50.7% | 126.2% | · | |
| ROIC | · | · | · | · | · | · | 48.2% | · | 12.8% | 45.7% | 15.8% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | · | 1.0 | · | 0.0 | 0.1 | 0.1 | · | |
| Quick Ratio | · | · | · | · | · | · | 0.8 | · | 0.0 | 0.0 | 0.1 | · | |
| Debt / Equity | · | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -7.3 | · | · | · | -4.7 | · | -30.7 | -152.5 | -18.6 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 1.2 | · | 1.0 | 0.1 | 0.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | 1.9 | · | 0.7 | 0.2 | · | · | |
| Receivables Turnover | · | · | · | · | · | · | 12.7 | · | 6.3 | 24.6 | 8.7 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $-0.02 | · | $-0.04 | $-0.03 | $-0.03 | · | |
| Revenue / Share | · | · | $1.93 | · | · | · | $0.01 | · | $0.00 | $0.00 | $0.00 | · | |
| Cash Flow / Share | · | · | $-3.04 | · | · | · | $0.01 | · | $-0.00 | $-0.00 | $-0.00 | · | |
| Cash / Share | · | · | · | · | · | · | $0.01 | · | $0.00 | $0.00 | $0.00 | · | |
| EPS (TTM) | $-214.64 | $-30.19 | $-67.37 | $-17.97 | $-0.63 | $-1.52 | $-0.45 | $-0.02 | $0.00 | $-0.02 | $-0.04 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.7% | 116.3% | 267.4% | -80.2% | 301.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 102.6% | 16.2% | 42.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 45.8% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $7M | $3M | $822.2K | $4M | $1M | $1M | $494.4K | $282.1K | $50.9K | $11.7K | · | |
| Net Income TTM | $-23M | $-9M | $-8M | $-11M | $-7M | $-8M | $-2M | $-3M | $-702.2K | $-2M | $-5M | · | |
| P/E | -0.0 | -1.0 | -0.7 | -17.0 | -3805.7 | -1425.8 | · | · | · | · | · | · | |
| P / Tangible Book | 17.9 | 3.0 | · | · | 3984.3 | 3698.6 | · | · | · | · | · | · | |
| Earnings Yield | -28504.6% | -103.5% | -138.6% | -5.9% | -0.03% | -0.07% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $974.9K | $315.9K | $348.0K | $278.1K | $235.3K | |
| Cost of Revenue | $60.1K | $5.2K | · | · | $3.1K | $4.0K | $-3M | $988.5K | $861.6K | $862.1K | $925.2K | $581.0K | $235.7K | $231.0K | · | $97.6K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | · | · | $275.5K | · | $126.2K | |
| R&D Expense | · | · | · | · | · | $265.7K | $0 | · | · | $4.9K | $5.9K | $2.7K | $83.8K | $73.5K | $73.8K | $175.3K | |
| SG&A Expense | $2M | $2M | $815.5K | $2M | $2M | $2M | $2M | $2M | $3M | $1M | $2M | $1M | $2M | $2M | $3M | $2M | |
| Operating Expenses | $3M | $4M | $-13M | $3M | $5M | $3M | $4M | $3M | $4M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | |
| Operating Income | $-1M | $-2M | $14M | $-2M | $-3M | $-1M | $-2M | $-1M | $-2M | $-2M | $-2M | $-886.3K | $-2M | $-2M | $-3M | $-3M | |
| Interest Expense | · | · | · | · | · | $-311.3K | · | · | · | $-181.3K | $182.0K | $352.1K | $175.2K | $216.6K | $56.1K | $1.8K | |
| Other Non-op | $2M | $-4M | $3M | $-2M | $1M | $-292.7K | $-194.1K | $-301.0K | $-390.3K | $-86.6K | $-463.3K | $-360.3K | $-171.7K | $-244.5K | $-46.7K | $-24.2K | |
| Pretax Income | $944.9K | · | $18M | $-3M | $-2M | $-17M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $-3M | $-3M | |
| Income Tax | $56.2K | $0 | · | · | · | $0 | $109.1K | $29.3K | · | $1.8K | $23.0K | $1.9K | $2.9K | · | $2.1K | · | |
| Net Income | $888.7K | $-6M | $2M | $-3M | $-4M | $-17M | $-4M | $-2M | $-2M | $-2M | $-2M | $-1M | $-2M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $0.42 | $-3.38 | $-188.04 | $-39.40 | $-364.23 | $-3473.93 | $-3737.60 | $-15.11 | $-22.39 | $-7.55 | $-59.51 | $-0.70 | $-3.06 | $-4.10 | $-8.93 | $-4.19 | |
| EPS (Diluted) | $0.35 | $-3.38 | $-188.04 | $-39.40 | $-364.23 | $-3473.93 | $-3737.60 | $-15.11 | $-22.39 | $-7.55 | $-59.51 | $-0.70 | $-3.06 | $-4.10 | $-8.93 | $-4.19 | |
| Shares (Basic) | 2,105,595 | 1,637,859 | · | 3,447,622 | 9,936 | 5,010 | · | 107,949 | 100,276 | 211,329 | · | 1,776,898 | 732,255 | 622,507 | · | 607,783 | |
| Shares (Diluted) | 2,592,025 | 1,637,859 | · | 3,447,622 | 9,936 | 5,010 | · | 107,949 | 100,276 | 211,329 | · | 1,776,898 | 732,255 | 622,507 | · | 607,783 | |
| EBITDA | $-1M | $-1M | · | $-2M | $-3M | $-17M | · | $-1M | $-2M | $-719.4K | · | $-886.3K | $-2M | $-2M | · | $-3M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $5M | $2M | $355.9K | $549.2K | $840.4K | $619.5K | $471.6K | $942.9K | $475.1K | $232.4K | $1M | $112.5K | $2M | $90.1K | $285.7K | |
| Receivables | $257.7K | $248.4K | $217.3K | $274.2K | $242.3K | $173.6K | $113.1K | $257.1K | $257.2K | $176.9K | $140.6K | $116.8K | $74.9K | $99.7K | $77.1K | $71.3K | |
| Inventory | $251.3K | $224.6K | $225.3K | $191.8K | $212.6K | $216.5K | $219.8K | $241.5K | $250.1K | $266.5K | $264.5K | $254.2K | $280.0K | $270.9K | $263.6K | $280.1K | |
| Prepaid Expense | $360.8K | $356.8K | $241.1K | $315.0K | $395.3K | $338.6K | $180.9K | $987.3K | $945.9K | $806.5K | $622.3K | $365.2K | $374.7K | $250.9K | $190.2K | $305.2K | |
| Current Assets | $5M | $6M | $3M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $842.1K | $3M | $621.1K | $942.3K | |
| PP&E (Net) | $832.9K | $474.6K | $386.2K | $405.4K | $428.7K | $451.2K | $466.7K | $415.2K | $441.4K | $412.2K | $826.4K | $772.4K | $659.4K | $417.6K | $436.7K | $456.4K | |
| Accum. Depreciation | $532.2K | $497.0K | $459.6K | $428.6K | $397.2K | $365.8K | $335.7K | $308.3K | $282.1K | $256.2K | $233.6K | $212.6K | $192.1K | $172.4K | $153.3K | $134.2K | |
| Goodwill | $9M | $7M | $6M | $6M | $6M | $9M | $6M | $6M | $6M | $6M | $6M | $8M | · | · | · | · | |
| Intangibles | $1M | $1M | $1M | $1M | $2M | $18M | $3M | $3M | $4M | $4M | $4M | $2M | · | · | · | $132.7K | |
| Total Assets | $26M | $25M | $20M | $19M | $19M | $32M | $46M | $17M | $18M | $18M | $19M | $19M | $7M | $6M | $4M | $5M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $2M | $5M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $689.6K | |
| Current Liabilities | $7M | $6M | $10M | $9M | $12M | $19M | $18M | $9M | $8M | $9M | $8M | $5M | $4M | $4M | $3M | $2M | |
| Capital Leases | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $6M | $4M | $2M | $1M | $2M | |
| Deferred Tax | $56.1K | · | · | · | · | · | $163.1K | · | · | · | · | $1.9K | $1.9K | $1.9K | $1.9K | $1.1K | |
| Other Non-current Liabilities | $79.7K | $79.7K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $9M | $10M | $13M | $13M | $17M | $24M | $26M | $17M | $16M | $18M | $18M | $19M | $8M | $6M | $5M | $3M | |
| Long-term Debt | $2M | $2M | $892.5K | $2M | $5M | · | $7M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $2M | $2M | · | $2M | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $229 | $164 | $239 | $542 | $83 | $74 | $37 | $391 | $386 | $262 | $20 | $247 | $83 | $1.4K | $61 | $1.2K | |
| Retained Earnings | $-96M | $-97M | $-91M | $-93M | $-90M | $-85M | $-67M | $-64M | $-62M | $-59M | $-58M | $-56M | $-55M | $-52M | $-50M | $-47M | |
| Stockholders' Equity | $16M | $15M | $7M | $6M | $3M | $3M | $13M | $-23.3K | $1M | $10.2K | $892.8K | $372.8K | $-2M | $88.5K | $-977.6K | $1M | |
| Liabilities + Equity | $26M | $25M | $20M | $19M | $19M | $32M | $46M | $17M | $18M | $18M | $19M | $19M | $7M | $6M | $4M | $5M | |
| Shares Outstanding | 2,295,035 | 1,640,635 | 477,366 | 5,423,801 | 828,110 | 746,227 | 3,111 | 3,906,072 | 3,864,072 | 2,618,031 | 207,711 | 2,474,756 | 826,886 | 13,971,283 | 608,611 | 12,165,964 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $145.6K | $142.7K | $136.4K | $136.7K | $169.7K | $234.5K | $231.8K | $230.5K | $230.3K | $227.0K | $141.6K | $20.5K | $19.7K | $19.1K | $19.9K | $19.7K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | · | $251.6K | $326.9K | $325.8K | · | $426.1K | |
| Amort. of Intangibles | $110.3K | $105.3K | $105.3K | $105.3K | $138.4K | $204.4K | $204.4K | $204.4K | $204.4K | $204.4K | $120.6K | $0 | $0 | $0 | $452 | $453 | |
| Other Non-cash | · | $3M | · | · | · | $14M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-1M | $-2M | $25.2K | $-2M | $-2M | $-4M | $-617.4K | $-640.8K | $-1M | $-260.6K | $-714.9K | $-1M | $-2M | $-1M | $-1M | $-2M | |
| CapEx | · | · | $11.8K | $8.1K | $8.9K | $14.7K | $78.9K | $0 | $55.1K | $49.7K | $75.0K | $108.2K | · | · | $-135 | $2.6K | |
| Investing Cash Flow | $-2.2K | $-210.0K | $-3M | $-8.1K | $-15.4K | $-14.7K | $393.1K | $0 | $-5.1K | $-24.1K | $33.3K | $-2M | $-261.5K | $-8.4K | $8.6K | $-3.0K | |
| Stock Issued | · | · | $4M | $0 | $0 | $9M | $0 | $0 | · | · | $-23.1K | $3M | $20.3K | $3M | $0 | $-25.2K | |
| Net Stock Activity | · | · | · | · | · | $9M | · | · | · | · | · | · | · | $3M | · | · | |
| Financing Cash Flow | $-67.8K | $5M | $4M | $2M | $1M | $4M | $494.1K | $169.5K | $2M | $527.4K | $-141.5K | $4M | $-169.9K | $3M | $800.0K | $-25.2K | |
| Net Change in Cash | $-1M | $3M | $2M | $-193.3K | $-291.2K | $99.0K | $269.8K | $-471.3K | $467.8K | $242.7K | $-823.1K | $943.1K | $-2M | $2M | $-195.6K | $-2M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $800 | $0 | $-2.0K | |
| Free Cash Flow | · | · | · | · | · | $-4M | · | · | · | $-310.3K | · | · | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-491.8K | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | 79.1% | · | 53.6% | |
| Operating Margin | -59.3% | -79.0% | · | -93.1% | -160.4% | -1044.9% | · | -90.7% | -103.6% | -60.0% | · | -90.9% | -654.0% | -662.7% | · | -1073.2% | |
| Net Margin | 40.8% | -274.9% | · | -150.5% | -283.6% | -1063.0% | · | -113.8% | · | -101.3% | · | -128.1% | -709.2% | -733.0% | · | -1083.5% | |
| Pretax Margin | 43.4% | · | · | -150.5% | -172.2% | -1063.0% | · | -111.7% | -122.2% | -101.2% | · | -127.9% | -708.3% | · | · | -1083.5% | |
| EBITDA Margin | -59.3% | -71.9% | · | -93.1% | -160.4% | -1030.6% | · | -90.7% | -103.6% | -45.6% | · | -90.9% | -654.0% | -657.2% | · | -1073.2% | |
| ROA | 3.9% | -19.6% | · | -14.8% | -28.5% | -69.5% | · | -8.9% | · | -13.1% | · | -10.3% | -34.3% | -34.8% | · | -39.8% | |
| ROE | 9.3% | -60.3% | · | -90.8% | -264.6% | -1040.4% | · | -933.2% | · | -3237.7% | · | -150.4% | -271.4% | -89.8% | · | -140.0% | |
| ROIC | -6.7% | · | · | · | · | · | · | 5679.2% | · | -9330.0% | · | -238.1% | 121.3% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.9 | · | 0.1 | 0.1 | 0.1 | · | 0.2 | 0.3 | 0.2 | · | 0.4 | 0.2 | 0.6 | · | 0.6 | |
| Quick Ratio | 0.6 | 0.8 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.0 | 0.5 | · | 0.2 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.3 | 1.8 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.0 | 0.0 | · | 0.2 | 0.4 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | 55.0 | · | · | · | -5.2 | · | -2.5 | -11.8 | -10.6 | · | -1434.1 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.3 | 0.0 | · | · | · | 4.4 | · | 4.0 | 3.3 | 3.2 | · | · | · | 0.2 | · | 0.3 | |
| Receivables Turnover | 8.7 | 9.6 | · | 6.6 | 7.5 | 9.3 | · | 7.7 | 11.1 | 11.4 | · | 10.4 | 4.8 | 4.4 | · | 3.9 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.19 | $9.16 | · | $1.08 | $3.18 | $4.47 | · | $-0.01 | $0.35 | $0.00 | · | $0.15 | $-2.06 | $0.01 | · | $0.11 | |
| Revenue / Share | $0.84 | $1.23 | · | $0.51 | $4.69 | $1.18 | · | $0.37 | $0.51 | $0.41 | · | $0.55 | $0.43 | $0.03 | · | $0.02 | |
| Cash Flow / Share | · | $-1.17 | · | · | · | $-2.55 | · | · | · | $-0.07 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $1.63 | $2.99 | · | $0.07 | $0.66 | $1.13 | · | $0.12 | $0.24 | $0.18 | · | $0.43 | $0.14 | $0.16 | · | $0.02 | |
| EPS (TTM) | $-230.47 | $-595.05 | · | $-7615.16 | $-7590.87 | $-7249.03 | · | $-104.56 | $-90.15 | $-70.82 | · | $-16.79 | $-20.28 | $-21.84 | · | $-9.01 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $7M | · | $7M | $7M | $7M | · | $6M | $6M | $4M | · | $2M | $1M | $1M | · | $4M | |
| Net Income TTM | $-6M | $-11M | · | $-28M | $-26M | $-25M | · | $-7M | $-7M | $-7M | · | $-9M | $-10M | $-11M | · | $-8M | |
| Market Cap | $4M | $4M | · | $4M | $2M | $4M | · | $100M | $117M | $107M | · | $70M | $119M | $6.43B | · | $9.29B | |
| Enterprise Value | $2M | $1M | · | $6M | $6M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | -0.2 | -0.3 | -0.6 | · | -1.7 | -7.1 | -21.1 | · | -84.7 | |
| P/S | 0.6 | 0.6 | · | 0.6 | 0.3 | 0.7 | · | 16.0 | 20.3 | 25.1 | · | 36.7 | 101.1 | 6379.3 | · | 2584.7 | |
| P/B | 0.3 | 0.3 | · | 0.7 | 0.8 | 1.3 | · | -4282.0 | 85.7 | 10487.6 | · | 188.8 | -69.8 | 72659.6 | · | 7213.2 | |
| P / Tangible Book | 0.7 | 0.6 | · | · | · | · | · | · | · | · | · | · | · | 72659.6 | · | 8042.2 | |
| P / Cash Flow | · | -2.3 | · | · | · | -1.3 | · | · | · | -408.7 | · | · | · | -5597.0 | · | · | |
| EV / Revenue | 0.3 | 0.2 | · | 0.8 | 1.0 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -12130.0% | -21876.8% | · | -1001994.7% | -287532.9% | -120817.2% | · | -409.1% | -298.1% | -174.1% | · | -59.0% | -14.1% | -4.8% | · | -1.2% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|---|
| Gelir | $7M | $7M | · | $3M | · |
| Faaliyet Kâr Marjı % | · | · | · | -224.0% | · |
| Net Gelir | $-23M | $-9M | · | $-8M | · |
| Seyreltilmiş Hisse Başı Kâr | $-214.64 | $-3782.65 | · | $-67.37 | · |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
| Metrik | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | · | $-5M | · |
Kurumsal Sahipler (13F) 2 dosya · $1 toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
2
Tutulan Değer
$1
Yeni pozisyonlar
0
Çıkan pozisyonlar
1
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 0 (-1 önceki Ç'ye göre) | 1 (-8 önceki Ç'ye göre) | 0 (0 önceki Ç'ye göre) | 0 (0 önceki Ç'ye göre) | -13 |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Westfuller Advisors, LLC | $1 | 1 | 100,00% | Hisse senetleri |
| HUNTINGTON NATIONAL BANK | $0 | 1 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| SS. OR ×3 başvurular | 08 Ağustos 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi | 19 Haziran 2017 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 13 içeriden öğrenenler · 4 yöneticiler · 10 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Steve Shum | Chief Executive Officer | 26 Ağustos 2025 A | 128.420 | 0 | 0 | $0 |
| Andrea Goren | Chief Financial Officer | 26 Ağustos 2025 A | 129.015 | 0 | 0 | $0 |
| Michael Jos. Campbell | Chief Operating Officer | 18 Mayıs 2023 A | 75.762 | 0 | 0 | $0 |
| Kevin Doody | Medical Director | 01 Haziran 2022 P | 0 | 0 | 0 | $0 |
| Matthew K Szot | Yönetim kurulu üyesi | 04 Aralık 2025 J | 0 | 0 | 1 | $-6 |
| Rebecca Messina | Yönetim kurulu üyesi | 26 Ağustos 2025 A | 23.045 | 0 | 0 | $0 |
| Barbara Ryan | Yönetim kurulu üyesi | 26 Ağustos 2025 A | 22.991 | 0 | 0 | $0 |
| Trent D Davis | Yönetim kurulu üyesi | 26 Ağustos 2025 A | 33.622 | 0 | 0 | $0 |
| Jeffrey Segal | Yönetim kurulu üyesi | 01 Haziran 2022 P | 28.220 | 0 | 0 | $0 |
| Kathleen T Karloff | Yönetim kurulu üyesi | 05 Şubat 2020 A | 13.200.183 | 0 | 0 | $0 |
| Robert Joseph Bowdring Jr | Yönetim kurulu üyesi | 29 Ekim 2019 J | 11.715.942 | 0 | 0 | $0 |
| AWM Investment Company, Inc. | 10% sahip | 10 Mayıs 2021 P | 1.159.075 | 0 | 0 | $0 |
| Claude Ranoux | 10% sahip | 03 Aralık 2018 S | 24.694.000 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
IVF Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 5 analist
AL
Medyan hedef
$20.00
+2239,2%
1 20,0%
Güçlü Al
3 60,0%
Al
1 20,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-09-30Ortalama hedef $20.00 +2239,2%
Düşük$20.00
Ortalama$20.00
Yüksek$20.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026